Patient-as-bioreactor in-body tissue architecture generates autologous multicellular constructs for durable diabetic wound repair

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

An in-body tissue architecture device was used in a first-in-human study to generate autologous multicellular constructs for sustained diabetic wound repair, achieving significant wound-area reduction without serious adverse events.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The preprint studied a patient-as-bioreactor strategy in which an in-body tissue architecture (iBTA) platform uses a temporary subcutaneous device to manufacture autologous multicellular regenerative “biococktails” for chronic diabetic foot ulcers. In a first-in-human exploratory study, 37 devices were implanted in 10 patients, and all 10 patients generated at least one construct meeting predefined quality criteria, followed by a single application leading to sustained wound-area reduction with a mean of 84.15% at 12 weeks. The authors report reproducible self-assembled multicellular niches with stem cell–associated programs, reparative macrophage signatures, nascent vasculature, extracellular matrix components, and broad regenerative signaling, with no amputations or treatment-related serious adverse events. The paper is a preprint and explicitly limited by its first-in-human exploratory design and undisclosed peer-review status; Relevance to endometriosis: the paper does not explicitly discuss endometriosis or adenomyosis, but it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Chronic diabetic foot ulcers remain refractory to contemporary care, partly because durable repair requires reconstruction of an integrated, multicellular regenerative niche—an outcome rarely achieved without complex ex vivo manufacturing. We advance a patient-as-bioreactor paradigm in which in-body tissue architecture (iBTA) repurposes the body for in vivo manufacturing of autologous multicellular regenerative constructs (“biococktails”) using a temporary subcutaneous device. In a first-in-human exploratory study, 37 devices were successfully implanted, and the primary endpoint—generation of ≥ 1 construct meeting predefined quality criteria—was achieved in all 10 patients. A single application initiated sustained wound repair, reaching a mean 84.15% wound-area reduction at 12 weeks. Reproducible, self-assembled niches enriched for stem cell–associated programs, reparative macrophage signatures, nascent vasculature, extracellular matrix components, and broad regenerative signaling were observed. No amputations or treatment-related serious adverse events occurred. These findings establish iBTA as a scalable, patient-specific in vivo manufacturing platform for multicellular regenerative therapies.
Full text 18,265 characters · extracted from preprint-html · click to expand
Patient-as-bioreactor in-body tissue architecture generates autologous multicellular constructs for durable diabetic wound repair | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Patient-as-bioreactor in-body tissue architecture generates autologous multicellular constructs for durable diabetic wound repair Ryuji Higashita, Yasuhide Nakayama, Ryosuke Iwai, Marina Funayama-Iwai, and 1 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8946692/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted You are reading this latest preprint version Abstract Chronic diabetic foot ulcers remain refractory to contemporary care, partly because durable repair requires reconstruction of an integrated, multicellular regenerative niche—an outcome rarely achieved without complex ex vivo manufacturing. We advance a patient-as-bioreactor paradigm in which in-body tissue architecture (iBTA) repurposes the body for in vivo manufacturing of autologous multicellular regenerative constructs (“biococktails”) using a temporary subcutaneous device. In a first-in-human exploratory study, 37 devices were successfully implanted, and the primary endpoint—generation of ≥ 1 construct meeting predefined quality criteria—was achieved in all 10 patients. A single application initiated sustained wound repair, reaching a mean 84.15% wound-area reduction at 12 weeks. Reproducible, self-assembled niches enriched for stem cell–associated programs, reparative macrophage signatures, nascent vasculature, extracellular matrix components, and broad regenerative signaling were observed. No amputations or treatment-related serious adverse events occurred. These findings establish iBTA as a scalable, patient-specific in vivo manufacturing platform for multicellular regenerative therapies. Biological sciences/Biotechnology/Biomaterials/Tissues Biological sciences/Stem cells/Regeneration Full Text Additional Declarations Yes there is potential Competing Interest. R.H. and Y.N. are stockholders of Biotube Co., Ltd. Y.N. is an executive board member of Biotube Co., Ltd. All other authors declare no competing interests. Tables are available in the Supplementary Files section. Supplementary Files Table3.pdf Table 3 Table2.pdf Table 2 Table1.pdf Table 1 Table4.pdf Table 4 SupplementarytableS2.pdf Supplementary Table S2 supplementarymaterials.pdf Supplementary methods SupplementarytableS1.docx Supplementary Table S1 Table3.docx Table 3 Table4.docx Table 4 SupplementaryTableS2.docx Supplementary Table S2 supplementarymaterials.docx Supplementary methods Table1.docx Table 1 Table2.docx Table 2 Cite Share Download PDF Status: Under Review Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8946692","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":608331938,"identity":"dfa8152c-0e24-4c2c-bc64-5546bb95948c","order_by":0,"name":"Ryuji Higashita","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0003-1337-192X","institution":"Juntendo University School of Medicine","correspondingAuthor":true,"prefix":"","firstName":"Ryuji","middleName":"","lastName":"Higashita","suffix":""},{"id":608331939,"identity":"82231798-62d0-41d4-8d17-b18a3222dcd8","order_by":1,"name":"Yasuhide Nakayama","email":"","orcid":"","institution":"Biotube Co. Ltd.","correspondingAuthor":false,"prefix":"","firstName":"Yasuhide","middleName":"","lastName":"Nakayama","suffix":""},{"id":608331940,"identity":"d71b16e8-9916-46fb-841d-00f6d92cf7f6","order_by":2,"name":"Ryosuke Iwai","email":"","orcid":"","institution":"Okayama University of Science,","correspondingAuthor":false,"prefix":"","firstName":"Ryosuke","middleName":"","lastName":"Iwai","suffix":""},{"id":608331941,"identity":"13b94510-11ef-4d76-84b8-ed717e924d31","order_by":3,"name":"Marina Funayama-Iwai","email":"","orcid":"","institution":"Okayama University of Science,","correspondingAuthor":false,"prefix":"","firstName":"Marina","middleName":"","lastName":"Funayama-Iwai","suffix":""},{"id":608331942,"identity":"36f87e3e-f702-4797-b44f-96d2bcdd5dc3","order_by":4,"name":"Tomohisa Sakaue","email":"","orcid":"https://orcid.org/0000-0001-7724-2225","institution":"Ehime University","correspondingAuthor":false,"prefix":"","firstName":"Tomohisa","middleName":"","lastName":"Sakaue","suffix":""}],"badges":[],"createdAt":"2026-02-23 11:46:53","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8946692/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8946692/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":105730508,"identity":"8449da90-ac51-41fa-bb56-9bd70a46b130","added_by":"auto","created_at":"2026-03-30 11:25:16","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1679769,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1_covered_e0705b9a-a6f2-4c7a-9c15-86048fb4d2ec.pdf"},{"id":105206741,"identity":"62283a6c-a21b-4b7d-9b87-e0eee1d85df6","added_by":"auto","created_at":"2026-03-23 12:58:04","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":132581,"visible":true,"origin":"","legend":"Table 3","description":"","filename":"Table3.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/5ddbeea47a5ad256a77698dd.pdf"},{"id":105206747,"identity":"482114c8-2f73-4445-8729-c179eab7114f","added_by":"auto","created_at":"2026-03-23 12:58:05","extension":"pdf","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":170394,"visible":true,"origin":"","legend":"Table 2","description":"","filename":"Table2.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/840b4f7c61ba8c19e0196021.pdf"},{"id":105206752,"identity":"dfa92a92-2cf0-419b-8a0d-be9f399fddf6","added_by":"auto","created_at":"2026-03-23 12:58:06","extension":"pdf","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":149723,"visible":true,"origin":"","legend":"Table 1","description":"","filename":"Table1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/031a6926b6cc6300eea2af8e.pdf"},{"id":105563756,"identity":"a2dedabf-95c6-404e-8536-fba2fdb91685","added_by":"auto","created_at":"2026-03-27 12:47:43","extension":"pdf","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":137088,"visible":true,"origin":"","legend":"Table 4","description":"","filename":"Table4.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/14588fc28013eeacdb924e5b.pdf"},{"id":105564230,"identity":"8fdb2ea3-2051-48e7-9f53-4a9b09bcba97","added_by":"auto","created_at":"2026-03-27 12:49:05","extension":"pdf","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":282120,"visible":true,"origin":"","legend":"Supplementary Table S2","description":"","filename":"SupplementarytableS2.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/647b29c1e0f7745b0b9ba185.pdf"},{"id":105564203,"identity":"58f563ef-63cb-41aa-9a5b-0857ba7084c1","added_by":"auto","created_at":"2026-03-27 12:48:59","extension":"pdf","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":203765,"visible":true,"origin":"","legend":"Supplementary methods","description":"","filename":"supplementarymaterials.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/8fd17859abfc4af87a5d4884.pdf"},{"id":105206744,"identity":"6272a139-071c-4330-bbdc-8b0d601a70c5","added_by":"auto","created_at":"2026-03-23 12:58:05","extension":"docx","order_by":7,"title":"","display":"","copyAsset":false,"role":"supplement","size":16296,"visible":true,"origin":"","legend":"Supplementary Table S1","description":"","filename":"SupplementarytableS1.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/1bcd428dbea0a35a97fd741f.docx"},{"id":105206742,"identity":"5d283401-6ca6-4fc9-a513-4d520fde4d27","added_by":"auto","created_at":"2026-03-23 12:58:04","extension":"docx","order_by":8,"title":"","display":"","copyAsset":false,"role":"supplement","size":18538,"visible":true,"origin":"","legend":"Table 3","description":"","filename":"Table3.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/5649963ccfaebed4fb0c3e76.docx"},{"id":105206746,"identity":"9f396f23-7bdd-481b-bdf5-a03bdfe84b13","added_by":"auto","created_at":"2026-03-23 12:58:05","extension":"docx","order_by":9,"title":"","display":"","copyAsset":false,"role":"supplement","size":17086,"visible":true,"origin":"","legend":"Table 4","description":"","filename":"Table4.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/ffde05360d81ed6990e58047.docx"},{"id":105206751,"identity":"9e4281a9-0971-4954-badd-610bc0df8ba6","added_by":"auto","created_at":"2026-03-23 12:58:06","extension":"docx","order_by":10,"title":"","display":"","copyAsset":false,"role":"supplement","size":34377,"visible":true,"origin":"","legend":"Supplementary Table S2","description":"","filename":"SupplementaryTableS2.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/ff8bcbba21358ee056ee5e57.docx"},{"id":105563656,"identity":"4ba0810e-b522-4f43-ac0b-2bab9e8a42ef","added_by":"auto","created_at":"2026-03-27 12:47:22","extension":"docx","order_by":11,"title":"","display":"","copyAsset":false,"role":"supplement","size":31402,"visible":true,"origin":"","legend":"Supplementary methods","description":"","filename":"supplementarymaterials.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/e1f0370dc76da12ac937fa62.docx"},{"id":105564211,"identity":"d3ab13c3-0b09-4c1e-a977-ac58b2e2610e","added_by":"auto","created_at":"2026-03-27 12:49:01","extension":"docx","order_by":12,"title":"","display":"","copyAsset":false,"role":"supplement","size":18449,"visible":true,"origin":"","legend":"Table 1","description":"","filename":"Table1.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/a770ff77baf1ef4e76f7dbcc.docx"},{"id":105206748,"identity":"7c569d27-2cc1-4519-b913-c649cbb3074e","added_by":"auto","created_at":"2026-03-23 12:58:05","extension":"docx","order_by":13,"title":"","display":"","copyAsset":false,"role":"supplement","size":23278,"visible":true,"origin":"","legend":"Table 2","description":"","filename":"Table2.docx","url":"https://assets-eu.researchsquare.com/files/rs-8946692/v1/598c79bba20de508c09c97f0.docx"}],"financialInterests":"\u003cp\u003e\u003cstrong\u003eYes\u003c/strong\u003e there is potential Competing Interest. R.H. and Y.N. are stockholders of Biotube Co., Ltd. Y.N. is an executive board member of Biotube Co., Ltd. All other authors declare no competing interests.\u003c/p\u003e\n\u003cp\u003eTables are available in the Supplementary Files section.\u003c/p\u003e","formattedTitle":"Patient-as-bioreactor in-body tissue architecture generates autologous multicellular constructs for durable diabetic wound repair","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-8946692/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8946692/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eChronic diabetic foot ulcers remain refractory to contemporary care, partly because durable repair requires reconstruction of an integrated, multicellular regenerative niche—an outcome rarely achieved without complex ex vivo manufacturing. We advance a patient-as-bioreactor paradigm in which in-body tissue architecture (iBTA) repurposes the body for in vivo manufacturing of autologous multicellular regenerative constructs (“biococktails”) using a temporary subcutaneous device. In a first-in-human exploratory study, 37 devices were successfully implanted, and the primary endpoint—generation of ≥ 1 construct meeting predefined quality criteria—was achieved in all 10 patients. A single application initiated sustained wound repair, reaching a mean 84.15% wound-area reduction at 12 weeks. Reproducible, self-assembled niches enriched for stem cell–associated programs, reparative macrophage signatures, nascent vasculature, extracellular matrix components, and broad regenerative signaling were observed. No amputations or treatment-related serious adverse events occurred. These findings establish iBTA as a scalable, patient-specific in vivo manufacturing platform for multicellular regenerative therapies.\u003c/p\u003e","manuscriptTitle":"Patient-as-bioreactor in-body tissue architecture generates autologous multicellular constructs for durable diabetic wound repair","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-03-23 12:57:02","doi":"10.21203/rs.3.rs-8946692/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"communications-medicine","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"commsmed","sideBox":"Learn more about [Communications Medicine](http://www.nature.com/commsmed)","snPcode":"43856","submissionUrl":"https://mts-commsmed.nature.com/cgi-bin/main.plex","title":"Communications Medicine","twitterHandle":"@commsmedicine","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Communications Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"e9fee953-6cde-49fa-a9f6-70d0476ad83a","owner":[],"postedDate":"March 23rd, 2026","published":true,"recentEditorialEvents":[{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-05-08T06:12:13+00:00","index":3,"fulltext":"This content is not available."},{"type":"reviewerAgreed","content":"This content is not available.","date":"2026-05-07T12:51:38+00:00","index":4,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-05-06T13:55:13+00:00","index":2,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2026-04-30T14:45:07+00:00","index":1,"fulltext":"This content is not available."}],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":64732611,"name":"Biological sciences/Biotechnology/Biomaterials/Tissues"},{"id":64732612,"name":"Biological sciences/Stem cells/Regeneration"}],"tags":[],"updatedAt":"2026-03-23T12:57:02+00:00","versionOfRecord":[],"versionCreatedAt":"2026-03-23 12:57:02","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8946692","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8946692","identity":"rs-8946692","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0